Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Current Assets: 2022-2023

Historic Current Assets for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $238.8 million.

  • Therapeutics' Current Assets fell 20.00% to $238.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $238.8 million, marking a year-over-year decrease of 20.00%. This contributed to the annual value of $275.4 million for FY2022, which is N/A change from last year.
  • Latest data reveals that Therapeutics reported Current Assets of $238.8 million as of Q3 2023, which was down 4.93% from $251.2 million recorded in Q2 2023.
  • In the past 5 years, Therapeutics' Current Assets registered a high of $343.8 million during Q1 2022, and its lowest value of $238.8 million during Q3 2023.
  • Over the past 2 years, Therapeutics' median Current Assets value was $275.4 million (recorded in 2022), while the average stood at $286.4 million.
  • Data for Therapeutics' Current Assets shows a maximum YoY fell of 23.11% (in 2023) over the last 5 years.
  • Over the past 2 years, Therapeutics' Current Assets (Quarterly) stood at $275.4 million in 2022, then decreased by 20.00% to $238.8 million in 2023.
  • Its last three reported values are $238.8 million in Q3 2023, $251.2 million for Q2 2023, and $270.3 million during Q1 2023.